Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The NHS Wales Shared Services Partnership (hosted by Velindre NHS Trust) are acting on behalf of Velindre NHS Trust who sought to award a contract for a Parenteral Systemic Anti-cancer Therapy (SACT) service. This service is to be provided on behalf of Velindre Cancer Centre which is part of Velindre University NHS Trust.
In recent years there has been a surge of new SACT approved by NICE / AWMSG, including immunotherapy to treat solid tumour cancers. This surge is associated with significant increased demand and associated pressure on resources, which will continue to grow as more drugs / indications are NICE approved. This requirement is to increase capacity in order to help meet SACT demand as required. The Medicines@Home Service, as part of the Pharmacy department at Velindre Cancer Centre, will operationally manage the service.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| LloydsPharmacy | - | - | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 1,800 days (≈4.9 yrs) | £4,201,314 initial term | 1 single bid — no competition | LloydsPharmacy | active |
Weightings from the notice.
Published by the buyer on this notice. Check the original notice — details change and are not updated here.